Association analyses of eQTLs of the TYRO3 gene and allergic diseases in Japanese populations.


Journal

Allergology international : official journal of the Japanese Society of Allergology
ISSN: 1440-1592
Titre abrégé: Allergol Int
Pays: England
ID NLM: 9616296

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 11 04 2018
revised: 07 06 2018
accepted: 07 07 2018
pubmed: 8 8 2018
medline: 2 4 2019
entrez: 8 8 2018
Statut: ppublish

Résumé

TYRO3 is a member of the TAM (TYRO3, AXL, MERTK) receptor tyrosine kinase family and functions to limit type 2 immune responses implicated in allergic sensitization. Recent studies have shown that multiple intronic variants of TYRO3 were associated with asthma, implying that genetic variation could contribute to errant immune activation. We therefore hypothesized that expression quantitative trait loci (eQTLs) of the TYRO3 gene influence the development of allergic diseases (including asthma and allergic rhinitis) in Japanese populations. We performed a candidate gene case-control association study of 8 eQTLs of TYRO3 on atopy, asthma, and allergic rhinitis using 1168 unrelated Japanese adults who had GWAS genotyping. We then examined the genetic impact of rs2297377 (TYRO3) on atopy and allergic rhinitis in 2 other independent Japanese populations. A meta-analysis of 3 Japanese populations (a total of 2403 Japanese adults) revealed that rs2297377 was associated with atopy and allergic rhinitis (OR = 1.29 and 1.31; P = 0.00041 and 0.0010, respectively). The risk allele at rs2297377 correlated with decreased expression of TYRO3 mRNA. The gene-gene interaction between HLA-DPB1 and TYRO3 was not significant with regard to sensitization. The estimated proportion of atopy and allergic rhinitis cases attributable to the risk genotype was 14% and 16%, respectively. Our study identified TYRO3 as an important susceptibility gene to atopy and allergic rhinitis in Japanese.

Sections du résumé

BACKGROUND BACKGROUND
TYRO3 is a member of the TAM (TYRO3, AXL, MERTK) receptor tyrosine kinase family and functions to limit type 2 immune responses implicated in allergic sensitization. Recent studies have shown that multiple intronic variants of TYRO3 were associated with asthma, implying that genetic variation could contribute to errant immune activation. We therefore hypothesized that expression quantitative trait loci (eQTLs) of the TYRO3 gene influence the development of allergic diseases (including asthma and allergic rhinitis) in Japanese populations.
METHODS METHODS
We performed a candidate gene case-control association study of 8 eQTLs of TYRO3 on atopy, asthma, and allergic rhinitis using 1168 unrelated Japanese adults who had GWAS genotyping. We then examined the genetic impact of rs2297377 (TYRO3) on atopy and allergic rhinitis in 2 other independent Japanese populations.
RESULTS RESULTS
A meta-analysis of 3 Japanese populations (a total of 2403 Japanese adults) revealed that rs2297377 was associated with atopy and allergic rhinitis (OR = 1.29 and 1.31; P = 0.00041 and 0.0010, respectively). The risk allele at rs2297377 correlated with decreased expression of TYRO3 mRNA. The gene-gene interaction between HLA-DPB1 and TYRO3 was not significant with regard to sensitization. The estimated proportion of atopy and allergic rhinitis cases attributable to the risk genotype was 14% and 16%, respectively.
CONCLUSIONS CONCLUSIONS
Our study identified TYRO3 as an important susceptibility gene to atopy and allergic rhinitis in Japanese.

Identifiants

pubmed: 30082152
pii: S1323-8930(18)30087-X
doi: 10.1016/j.alit.2018.07.004
pii:
doi:

Substances chimiques

Receptor Protein-Tyrosine Kinases EC 2.7.10.1
TYRO3 protein, human EC 2.7.10.1

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-81

Informations de copyright

Copyright © 2018 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Auteurs

Jun Kanazawa (J)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.

Hironori Masuko (H)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan. Electronic address: hmasuko@md.tsukuba.ac.jp.

Yohei Yatagai (Y)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.

Tohru Sakamoto (T)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.

Hideyasu Yamada (H)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.

Haruna Kitazawa (H)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.

Hiroaki Iijima (H)

Tsukuba Medical Center, Tsukuba, Japan.

Takashi Naito (T)

Tsukuba Medical Center, Tsukuba, Japan.

Takefumi Saito (T)

National Hospital Organization Ibarakihigashi National Hospital, Tokai, Japan.

Emiko Noguchi (E)

Department of Medical Genetics, University of Tsukuba, Tsukuba, Japan.

Tomomitsu Hirota (T)

The Jikei University School of Medicine, Tokyo, Japan.

Mayumi Tamari (M)

The Jikei University School of Medicine, Tokyo, Japan.

Nobuyuki Hizawa (N)

Department of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH